Volume Alert - ACT 253.12 Actavis Inc $ACT Hit a high today

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
Volume Alert - ACT 253.12 Actavis Inc $ACT Hit a high today of 255.51 Closing the day 10:30 at 253.12 +9.35 +3.84% With a day low of 243.00 and a total volume of 8,102,117.

ACT Recent Posts: http://investorshangout.com/Actavis-Inc-ACT-53105/

ACT Actavis Inc Recent Headline News


Actavis to spend $66B on Allergan
By TOM MURPHY - AP - 9 mins ago
Actavis will pay $66 billion to buy fellow drugmaker Allergan in a deal that could finally end a months-long takeover push from Valeant Pharmaceuticals for the Botox maker.
DRTX: 23.90 (+0.15), AGN: 212.64 (+13.99), ACT: 253.16 (+9.39), VRX: 135.73 (+1.52), VRX.TO: 153.77 (+2.30)

Stock Market Today: Stocks Shrug Off Japan's Recession as Deals Dominate Day
at The Street - 16 mins ago
U.S. stocks recover from earlier lows triggered by Japan's recession. Deals news about Baker Hughes and Allergan dominate headlines.
AGN: 212.61 (+13.96), HAS: 56.20 (+2.18), ACT: 253.16 (+9.39), HAL: 51.14 (-3.94), DWA: 22.38 (-3.64), BHI: 67.49 (+7.60)

ALLERGAN, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
PR Newswire - 24 mins ago
Rigrodsky & Long, P.A.:
AGN: 212.64 (+13.99), ACT: 253.16 (+9.39)

Actavis Nabs Allergan For $66 Billion; Valeant Folds
at Investor's Business Daily - 39 mins ago
One of the most widely rumored deals in pharma came to fruition Monday, as Actavis (ACT) agreed to acquire Allergan (AGN) for $66 billion in cash and stock. Allergan stock was up more than 7%, near 213, and Actavis stock up nearly 4%, near 253, in...
AGN: 212.61 (+13.96), VRX: 135.73 (+1.52), ACT: 253.16 (+9.39)

Time to move on: Valeant chief says $219 too rich
Seeking Alpha - at Seeking Alpha - 42 mins ago

ACT: 253.29 (+9.52), VRX: 135.73 (+1.52)

Valeant Comments On Allergan Announcement
PR Newswire - 1 hr 27 mins ago
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) today commented on the announcement that Allergan, Inc. (NYSE: AGN) and Actavis plc (NYSE: ACT) have entered into a definitive agreement under which Actavis will acquire all outstanding shares of Allergan stock.
AGN: 212.61 (+13.96), ACT: 253.29 (+9.52), VRX: 135.73 (+1.52), VRX.TO: 153.77 (+2.30)

It's official: Actavis buys Allergan
Seeking Alpha - at Seeking Alpha - 1 hr 29 mins ago

AGN: 212.61 (+13.96), ACT: 253.29 (+9.52)

Actavis to Acquire Allergan to Create Top 10 Global Growth Pharmaceutical Company with $23 Billion in Revenue
PR Newswire - 1 hr 41 mins ago
Actavis plc (NYSE: ACT) and Allergan, Inc. (NYSE: AGN) today announced that they have entered into a definitive agreement under which Actavis will acquire Allergan for a combination of $129.22 in cash and 0.3683 Actavis shares for each share of Allergan common stock. Based on the closing price of Actavis shares on November 14, 2014, the transaction is valued at approximately $66 billion, or $219 per Allergan share. The combination will create one of the top 10 global pharmaceutical companies by sales revenue, with combined annual pro forma revenues of more than $23 billion anticipated in 2015. The transaction has been unanimously approved by the Boards of Directors of Actavis and Allergan, and is supported by the management teams of both companies. Actavis anticipates that the expected permanent financing structure, consisting of a combination of new equity and debt, will support an investment grade rating and provide long-term financing flexibility.
AGN: 212.61 (+13.96), ACT: 253.29 (+9.52)

Stock Futures Set For Weak Open; Halliburton, Baker Hughes Merge
at Investor's Business Daily - 1 hr 44 mins ago
Stock futures pointed modestly lower ahead of Monday's open as merger news stirred some of the most notable premarket stock moves. Dow futures sifted 27.7 points below fair market value. Nasdaq 100 futures were 9.1 points lower, and S&P 500 futures...
AGN: 212.61 (+13.96), HAS: 56.20 (+2.18), VRX: 135.73 (+1.52), ACT: 253.29 (+9.52), HAL: 51.15 (-3.93), DIS: 90.55 (-0.25), DWA: 22.38 (-3.64), BHI: 67.48 (+7.59)

Today's Market: Pharma And Tech Companies In Focus This Morning
Matthew Smith - at Seeking Alpha - 1 hr 50 mins ago

AGN: 212.61 (+13.96), VRX: 135.77 (+1.56), ACT: 253.29 (+9.52), LNKD: 225.05 (-8.84), FB: 74.71 (-0.17), MSFT: 49.34 (-0.24), GOOG: 537.00 (-7.40)

Actavis Rumored to be Close to Acquiring Allergan - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 1 hr 56 mins ago
As per market rumors, Actavis (ACT) is closing in on a deal to acquire Allergan (AGN) for over $65.5 billion.
DRTX: 23.91 (+0.16), ZTS: 43.75 (+0.61), AGN: 212.61 (+13.96), ACT: 253.29 (+9.52), VRX: 135.77 (+1.56)

Stock Market Today: Japan’s Surprise Recession Weighs on U.S. Stock Futures
at The Street - 2 hrs 16 mins ago
U.S. stock futures trade lower on Monday, weighed down by Japan's return into recession.
AGN: 212.61 (+13.96), ACT: 253.29 (+9.52), HAL: 51.15 (-3.93), TSN: 42.46 (+1.80), JD: 25.83 (-1.18), BHI: 67.49 (+7.60), BABA: 114.92 (-0.18)

Actavis Successfully Completes Durata Therapeutics, Inc. Tender Offer
PR Newswire - 2 hrs 56 mins ago
Actavis plc (NYSE: ACT) today announced that it has successfully completed its tender offer to purchase all outstanding shares of Durata Therapeutics, Inc. (NASDAQ: DRTX), an innovative pharmaceutical company focused on the development and commercialization of novel therapeutics for patients with infectious diseases and acute illnesses. As previously announced, Actavis offered to purchase all outstanding shares of Durata for $23.00 per share in cash, or approximately $675 million in the aggregate, and one contingent value right (CVR) per share, entitling the holder to receive additional cash payments of up to $5.00 per CVR if certain regulatory or commercial milestones related to Durata's lead product DALVANCETM are achieved.
DRTX: 23.91 (+0.16), ACT: 253.29 (+9.52)

Tracking Bill Ackman's Pershing Square Portfolio - Q3 2014 Update
John Vincent - at Seeking Alpha - Mon Nov 17, 6:40AM CST

ZTS: 43.75 (+0.61), AGN: 212.65 (+14.00), HLF: 38.52 (+0.02), VRX: 135.71 (+1.50), ACT: 253.19 (+9.42), HHC: 143.00 (-0.68), PAH: 25.69 (+0.19), CP: 206.40 (+1.84), APD: 135.48 (+0.77), BKW: 32.09 (-0.20)

Wall Street Breakfast: Nikkei Dives As Japan Slips Into Recession
Wall Street Breakfast - Seeking Alpha - Mon Nov 17, 5:30AM CST
Outstanding Performance Article Rewards We're excited to announce our latest two Outstanding Performance award winners. Each author receives $2,500. Read more about our Outstanding Performance award winners here . Winner #1: Top long idea...
VRX: 135.71 (+1.50), ACT: 253.19 (+9.42), F: 15.41 (+0.27), FB: 74.71 (-0.17), PFE: 30.04 (-0.30), AGN: 212.61 (+13.96), YHOO: 51.17 (-0.58), PBR: 9.57 (-0.38), DFS: 64.89 (-0.09), DTSI: 32.96 (-0.07), SPY: 204.11 (-0.13), LNKD: 225.05 (-8.84), QQQ: 102.89 (-0.33), AME: 51.19 (-0.51), MRK: 59.80 (+0.73), AOL: 46.08 (+0.04), AZN: 72.37 (-0.48), GM: 32.17 (+0.38), CVEO: 10.64 (unch), DD: 70.60 (-0.20)

Actavis near deal to acquire Allergan for $210-220/share
Seeking Alpha - at Seeking Alpha - Sun Nov 16, 2:51PM CST

AGN: 212.61 (+13.96), ACT: 253.19 (+9.42), VRX: 135.71 (+1.50)

Eye Best Mutual Funds Like Magellan For Great Stocks
at Investor's Business Daily - Fri Nov 14, 4:50PM CST
Leery about picking stocks on your own? Novice traders with little knowledge or confidence to pick winning stocks may benefit by first seeing what great mutual funds are buying. Funds rule the market. After all, they spend millions, even billions, of...
KMX: 54.60 (-1.05), ACT: 253.19 (+9.42), APH: 50.84 (-0.02), JPM: 60.29 (+0.01), ALXN: 189.83 (+1.07), GOOGL: 547.96 (-7.23), BAC: 17.12 (-0.02), NXPI: 74.05 (+0.32), MSFT: 49.32 (-0.26), VZ: 51.28 (-0.22), AAPL: 114.55 (+0.37), UNP: 120.61 (-0.10)

Mallinckrodt Shares Down on Setback for Generic Concerta - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 2:39PM CST
Mallinckrodt (MNK) received a setback when the FDA informed the company that its methylphenidate hydrochloride extended-release tablets, USP (CII) might not be therapeutically equivalent to Johnson & Johnson's (JNJ) Concerta.
MNK: 88.87 (+0.76), BIIB: 306.59 (+1.16), JNJ: 108.37 (+0.21), ACT: 253.19 (+9.42)

Valeant Should Drop Allergan Bid And Go For Zoetis
Kanak Kanti De - at Seeking Alpha - Fri Nov 14, 7:30AM CST

ZTS: 43.75 (+0.61), AGN: 212.53 (+13.88), VRX: 135.71 (+1.50), ACT: 253.19 (+9.42)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Voltage Energy's Microgrid Launches at RE+ 2026

Updated Category News Views 192

Voltage Energy Unveils New Power Systems In the swirling chaos of energy innovation, Voltage Energy is trying to carve its path at the heart of RE+ 2026. Out in Las Vegas, amidst the buzz of renewable energy tech, they introduced their Microgrid System (MGS) along with two new electrical balance of system (EBOS) products—the Load Break Disconnect Box (LBD) and Combiner...

Continue Reading
ETCO Targets the Unflashy Weak Link in Battery Storage

Updated Category News Views 0

A battery cabinet can look impressive right up until one lousy connection becomes the problem nobody budgeted for. ETCO Incorporated’s new lineup of standard and custom connectors and terminals goes after that unglamorous part of battery energy storage systems: the physical handoff points carrying power, grounding equipment, and tying auxiliary components together. It...

Continue Reading
Holiday Grease Advice Shows Utility Work Up Close Today

Updated Category News Views 117

Butter and pan drippings are mundane right until they become a backed-up kitchen line on a crowded holiday afternoon. New Jersey American Water's Nov. 17, 2026 reminder is not glamorous utility news, and frankly it is not trying to be. It is a practical warning: fats, oils and grease can cool, harden and accumulate in household pipes and farther along the wastewater...

Continue Reading
Insider Risk Makes Human Judgment a Security Priority

Updated Category News Views 87

A badge, a password, and a locked gate can all look reassuring right up until the person holding them starts to crack. Signpost Six's new report, The Psychology of Insider Risk, lands on an uncomfortable truth: the most consequential security weakness may not be a system at all. It may be an employee under strain, in conflict, in debt, making a mistake, or being quietly...

Continue Reading
COPD Support Program Targets a Costly Care Gap Today

Updated Category News Views 16

Breathing trouble gets shrugged off far too easily, and that casual mistake has consequences. World COPD Day puts chronic obstructive pulmonary disease back in view, with the American Lung Association emphasizing a free Lung Health Navigator program for people living with COPD, their caregivers and families. This is not flashy medicine or a miracle-cure pitch. It is...

Continue Reading
Sola's 11-Step Push Makes Salon Ownership Less Blind

Updated Category News Views 253

A pristine studio does not pay rent by itself. That is the uncomfortable little truth sitting underneath Sola Salons’ new 11-step roadmap for beauty professionals considering salon-suite ownership. The company is telling stylists, estheticians, nail technicians, massage therapists, and other independent operators to treat the move from commission work to ownership like...

Continue Reading
MobileX's $10 Plan Puts Holiday Pressure on Wireless

Updated Category News Views 157

A sixty-dollar commitment is a small bet, but in wireless it can become a loud little nuisance for every carrier charging far more. MobileX has rolled out a Black Friday offer giving new customers 10GB of high-speed data, unlimited talk and text, and six months of service for $60 upfront. That pencils out to $10 a month, before taxes and government surcharges, and it runs...

Continue Reading
Bona's 2027 Floorcast Finds Wood and Trust Still Win

Updated Category News Views 264

Floors are turning into a long-game purchase again Gray flooring may be limping toward the exit, but the more important signal in Bona's 2027 Floorcast is that homeowners are thinking less like bargain hunters and more like custodians of an expensive asset. That is a useful read for anybody watching the home-improvement and maintenance landscape. People do not replace a...

Continue Reading
Toledo Crosswalk Death Lawsuit Raises Hard Questions

Updated Category News Views 249

A painted crosswalk is supposed to mean something, and that is the grim center of the lawsuit filed over Judy Tanner’s death in Toledo. Tanner, 20, was walking home from work on September 10, 2026, when she was struck and killed while crossing the street. Her estate is now suing, alleging that the 31-year-old driver failed to yield as Tanner legally used the crosswalk....

Continue Reading
Modexus Opens a $500 Million Buyback With Real Caveats

Updated Category News Views 0

A half-billion-dollar buyback authorization can make a stock crowd sit up fast, and Modexus Solutions has plainly chosen that moment. On November 18, 2026, the Racine, Wisconsin-based thermal-management company said its board authorized repurchases of up to $500 million of common stock. For holders of NYSE:MOD, that is a meaningful declaration of intent. It says...

Continue Reading

Top 5 Most Recently Viewed Articles

IASO Bio Achieves Major Milestone with Orphan Drug Status

Updated Category News Views 270

IASO Bio Earns Orphan Drug Designation for Breakthrough Therapy IASO Biotherapeutics, a key player in the biopharmaceutical sector, announced an exciting achievement as its groundbreaking treatment, Equecabtagene Autoleucel (Fucaso), received Orphan Drug Designation from the Ministry of Food and Drug Safety. This recognition is particularly significant for adults fighting...

Continue Reading
Transforming Experience: Honda Center's $1 Billion Revamp

Updated Category News Views 387

Transforming Experience: Honda Center's $1 Billion Revamp Honda Center Encore Is A Multi-Year Investment Led by the Samueli Family That Will Redefine the Arena Experience OC Sports & Entertainment (OCSE), connected with the operator of Honda Center, has announced a groundbreaking project known as Honda Center Encore. This ambitious venture involves a significant...

Continue Reading
PIMCO Municipal Income Fund Faces Market Pressures at New Lows

Updated Category News Views 192

PIMCO Municipal Income Fund's Recent Market Performance PIMCO Municipal Income Fund (PMF) has recently faced significant market challenges, as evidenced by its stock hitting a notable 52-week low at a price of $8.82. This decline isn't merely an isolated incident; it reflects ongoing pressures impacting the broader fixed-income sector. Investors are currently navigating...

Continue Reading
Exploring Non-Surgical Solutions for Prostate Health Issues

Updated Category News Views 174

Prostate health became a hot topic for many men over 50, especially with the rise of benign prostatic hyperplasia (BPH)—that uncomfortable enlargement that turns bathroom trips into sprints. Back then, treatment options were shaking up, and PAE was coming onto the scene like it owned the place. PAE vs. Traditional Surgery: The Fight for Relief In an era where...

Continue Reading
Applied Digital Appoints Laura Laltrello as COO for AI Growth

Updated Category News Views 245

Applied Digital Names Laura Laltrello as New COO Applied Digital Corporation (NASDAQ: APLD) is excited to announce the appointment of Laura Laltrello as its new Chief Operating Officer (COO). With an aim to strengthen the Company’s leadership in next-generation data centers and digital cloud solutions, Ms. Laltrello's role signifies a pivotal moment in the Company’s...

Continue Reading